National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Kaposi Sarcoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 05/16/2008
AIDS Clinical Trials Group Staging Classification

  Good Risk (0)   Poor Risk (1)  
(Any of the following) (Any of the following)
Tumor (T) Confined to skin and/or lymph nodes and/or minimal oral disease [Note: Minimal oral disease is non-nodular KS confined to the palate.] Tumor-associated edema or ulceration
Extensive oral KS
Gastrointestinal KS
KS in other non-nodal viscera
Immune system (I) CD4 cells ≥ = 200/microL CD4 cells <200 per cubic millimeter
Systemic illness (S) No history of OIs or thrush [Note: OIs are opportunistic infections.] History of OIs and/or thrush
No “B” symptoms [Note: “B” symptoms are unexplained fever, night sweats, >10% involuntary weight loss, or diarrhea persisting >2 weeks.] “B” symptoms present
Performance status ≥70 (Karnofsky) Performance status <70
Other HIV-related illness (e.g., neurological disease or lymphoma)


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov